gastric cancer
Conditions
Interventions
The treatment group:Hyperthermic Intraperitoneal Chemotherapy
Sponsors
Second Affiliated Hospital, Zhejiang University College of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patient with no chemotherapy or radiotherapy prior to the start of the clinical trials, the pathological diagnosis of gastric cancer, patients with clinical stage of progress stage T3/4 (endoscopic ultrasound and enhancement CT and ultrasound imaging) (AJCC seventh edition in 2010), male or non pregnancy women, ranging in age from 18 to 70 years old, hematologic studies: 4000 cells/mm3 WBC count, neutrophil 1500 cells/mm3, platelet count > 100000 cells/mm3, hemoglobin > 9 g/l, biochemical examination: total bilirubin < 1.5 times that of the upper limit of normal, AST, ALT < 2.5 times the normal limit, creatinine < 1.5 times that of the normal limit function status: 0-2 (ECOG), has obtained the patient's informed consent.
Exclusion criteria
Exclusion criteria: Itraoperative intraperitoneal free cancer cells and peritoneal cancer was found in patients. patients with recurrence and distant metastasis, and other difficult to control the serious disease (including atrial fibrillation, angina pectoris, cardiac insufficiency, ejection fraction less than 50%, is difficult to control high blood pressure, etc.) were excluded. Others were treated with other clinical trials of cancer drugs. nonadherence or researchers believe could not complete the entire test treatment, extensive adhesion of abdominal cavity existence, refuse to sign a consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1, 3, 5 years overall survival rate; | — |
Countries
China
Contacts
Public ContactWu Dan
Second Affiliated Hospital, Zhejiang University College of Medicine
Outcome results
None listed